Notice of Intent to Single Source The 99th Contracting Squadron intends to award a single source contract to Ortho Clinical Diagnostics Inc. located at 1001 Rte 202 US Hwy, Raritan, NJ 08869 under the authority of FAR 13.106-1(b) Soliciting From A Single Source. The 99MDG Mike O’ Callagham Military Medical Center requires the Ortho Vision Analyzer Maintenance Agreement provided by Ortho Clinical Diagnostics. This notice of intent is not a request for competitive proposals and no solicitation document exists for the requirement. Sources interested in responding to this notice are required to submit a capability statement that includes technical data and cost information, sufficient detail and with convincing evidence that clearly demonstrates the capability to provide the required maintenance agreement Capability statements shall not exceed 5 (8.5 x 11 inch) pages using a font size no smaller than 10-point. All capability statements received by the closing date of this notice will be considered by the Government. A request for documentation or additional information or submissions that only ask questions will not be considered as an affirmative response. A determination by the Government not to compete based on responses to this notice is solely within the discretion of the Government. Information received will be considered solely for the purpose of determining whether to conduct a competitive procurement or to proceed with a single source purchase order. The following is a statement of the contractor’s unique qualifications and why the nature of this acquisition requires the use of the authority cited above: Ortho Clinical Diagnostics is the only source that can provide a complete maintenance agreement for the proprietary Ortho Vision Analyzer ID-Micro Typing System. Included in this maintenance agreement are software upgrades and 24/7 customer technical support. The Ortho Vision Analyzer specifically was purchased, in October 2019, due to its ability to perform automated anti-A and anti-B titers in order to facilitate a walking blood donor program at Nellis AFB, as well as other automated testing capabilities not found elsewhere on the market at the time. In addition, purchasing another brand of analyzer would require a separate validation between current and new methodology. The MOMMC has already invested in excess of $100,000.00 in the Ortho Vision Analyzer. This includes not only the initial purchase price but all startup and training cost as well. In summary, to procure another brand of analyzer would result in a substantial duplication of cost not expected to be recovered through full and open competition. Responses are due by 2:00 pm Pacific Daylight Time, 30 October 2020. Responses shall be submitted by email ONLY as a Microsoft Word or Adobe PDF attachment to the following address(es):
[email protected].